Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates...
28 insider purchases on record · latest filing 2024-03-25.
Insiders have also filed 8 sale transactions at DSGN.